HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutrition summit

This article was originally published in The Tan Sheet

Executive Summary

USDA and HHS seek input at a Dec. 9 public meeting on planning the National Nutrition Summit, tentatively slated for May 30-31 in Washington, D.C. The summit is intended to highlight accomplishments in the areas of food, nutrition and health since the last 1969 White House conference, as well as focus attention on nutrition and lifestyle issues across the lifespan. The Tufts University School of Nutrition, Science & Policy has been a major advocate of the conference (1"The Tan Sheet" Aug. 9, p. 5). For more information, contact Shanthy Bowman of the Agricultural Research Service at (301) 504-0619 or Paul Coates of NIH at (301) 435-2920

You may also be interested in...



Tufts Convening Coalition To Set Nutrition Priorities, Agenda

The Tufts University School of Nutrition, Science & Policy is inviting members of food- and nutrition-related industry groups, consumer advocacy groups, academia, industry and government to convene in an "iterative process" to identify issues and set priorities for nutrition research and policy. It is estimated the group will include about 35 people.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel